COMPANY REGISTRATION NUMBER: 01983718
CHARITY REGISTRATION NUMBER: 293754
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee Unaudited financial statements
30 November 2024
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Financial statements
Year ended 30 November 2024
| Page | |
|---|---|
| Trustees' annual report (incorporating the directors' report) | 1 |
| Independent examiner's report to the trustees | 9 |
| Statement of financial activities (including income and expenditure account) | 10 |
| Balance sheet | 11 |
| Notes to the financial statements | 12 |
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Trustees' annual report (incorporating the directors' report)
Year ended 30 November 2024
The trustees, who are also the directors for the purposes of company law, present their report and the unaudited financial statements of the charity for the year ended 30 November 2024.
The financial statements have been prepared in accordance with the accounting policies set out in notes to the accounts and comply with the charity's governing document, the Charities Act 2011 and Companies Act 2006 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland published in October 2019.
Reference and administrative details
Registered charity name
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Charity registration number 293754 Company registration number 01983718 Principal office and registered Royal College of Surgeons of England office College of Clinical Perfusion Scientists Fifth Floor Lincoln's Inn Fields London WC2A 3PE
The trustees
The trustees who served during the year and at the date of approval were as follows:
A Ahmed (resigned April 2025) A Brennan (Treasurer) B Pates (resigned April 2024) J O'Neill (Secretary) P Fricker (Chair) J Tyrrell B Pate A Murton C Boynton (resigned April 2025) B Evans (appointed April 2024) A Beatson F Holmes (appointed July 2025) L Kerr (appointed November 2024) J Youdle (appointed November 2024)
- 1 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Trustees' annual report (incorporating the directors' report) (continued)
Year ended 30 November 2024
Independent examiner Mark Proctor FCA DChA Lovewell Blake LLP Chartered accountants Bankside 300 Peachman Way Broadland Business Park Norwich NR7 0LB Bankers Barclays Bank PLC Barclays Banking Leicester LE87 2BB
- 2 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Trustees' annual report (incorporating the directors' report) (continued)
Year ended 30 November 2024
Objectives and activities
Professional registration and regulation of Clinical Perfusion Scientists in Great Britain and Ireland
The College is the professional governing body of Clinical Perfusion Scientists in Great Britain and Ireland and holds the register of all Clinical Perfusion Scientists that are eligible to practice within Great Britain and Ireland. The College works to ensure that all registered Clinical Perfusion Scientists are fit to practice. This is defined through an ability to uphold the standards and codes of practice as set by the Society of Clinical Perfusion Scientists of Great Britain and Ireland (SCPSGBI) and by working in accordance with the code of ethical conduct (a joint document by the College and SCPSGBI). The College ensures that all individuals maintain competency by completing a minimum amount of clinical work whilst maintaining continuing professional development through education.
The College will investigate and discipline individuals whose conduct falls short of the required standards. At this time the profession has not achieved statutory regulation and as a result, the College undertakes the regulation of Clinical Perfusion Scientists. This includes conducting disciplinary hearings and the striking off from the register of any Clinical Perfusion Scientist as required. The College must ensure all practicing Clinical Perfusion Scientists within the Great Britain and Ireland are competent to practice and ensure that patient safety is paramount. The College will seek legal advice when necessary and on occasions instruct a law firm to act on the College's behalf. The continued lack of statutory professional regulation of Clinical Perfusion Scientists brings with it the challenges of obtaining access to required information, which other governing bodies would automatically access.
In complex disciplinary cases, the College Council establishes a profession practice committee (PPC) to investigate, review evidence of alleged misconduct and determine what, if any, disciplinary action is deemed appropriate. The PPC will seek legal advice to ensure that it follows policy and law and responds accordingly to individual's legal advisors. There are governance costs which may include the cost of obtaining Counsel's advice in specific points of law and/or procedure.
Accreditation of Perfusion Departments to ensure standards in practice and training
The College undertakes assessment of perfusion practice in hospitals that have a cardiac centre, with resultant accreditation if appropriate standards of practice and training are evident. The College highlights any areas of concerns raised as a result of a site assessment and details an action log of recommendations and resulting criteria to be brought up to standard before full accreditation is granted. Accreditation is reassessed every 5 years. Perfusion departments can also request urgent College visits if there is concern regarding safe practice and patient care.
Training and Education
The College will liaise with and consult with the Society of Clinical Perfusion Scientists of Great Britain and Ireland, to advance education in the knowledge and practice of perfusion and related studies for the benefit of the public. A recurring contribution from the College to the Society will aid in the advancement of Perfusion education. This includes liaising and consulting with other professional bodies and institutions deemed necessary in pursuing these objectives.
Derivation of Funds
The College's funds are derived from revenue generated from both NHS and private health sector for hospital site accreditation certification and from the annual re-registration fees from all Clinical Perfusion Scientists on the professional register. A small additional amount of income is also derived from course validation fees and late payment fees.
- 3 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Trustees' annual report (incorporating the directors' report) (continued)
Year ended 30 November 2024
Objectives and activities (continued)
Public Benefit
The Trustees have considered the Charity Commission's requirement in respect of Public Benefit; in their view the Charity meets, in full, the criteria to satisfy the test.
- 4 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Trustees' annual report (incorporating the directors' report) (continued)
Year ended 30 November 2024
Achievements and performance
The college of Clinical Perfusion Scientists of Great Britain and Ireland hold the following membership registration details as of November 2024:
-
503 Clinical Perfusion Scientists with full registration
-
3 Clinical Perfusion Clinical Perfusion Scientists on extension
-
5 Clinical Perfusion Scientists on extended leave
-
60 trainee Clinical Perfusion Scientists
-
8 limited registration Clinical Perfusion Scientists
The College has continued the programme of assessing Clinical Perfusion Scientists and Perfusion centres in order to maintain the accepted professional standards required and to provide on-going clinical perfusion guidance. The College undertook 7 category one hospital site accreditation visits and 1 category 2 visit to perfusion departments in the UK and Ireland between 1st December 2023 to 30th November 2024. Unfortunately, there is still a backlog of accreditation visits that have surpassed the 5-year reaccreditation timeframe that occurred due to an inability to carry out these visits during the COVID-19 pandemic. The College is continuously working to reduce this backlog with attempts to carry out additional visits when possible. The visits rely completely on volunteer assessors from the Perfusion membership and College Council to undertake the assessments which can be difficult to populate the visit calendar as they all maintain posts as Clinical Perfusion Scientist in both NHS and private hospitals. However, the Secretary of the College is trialling a new system in the next financial period to minimise the difficulty in finding volunteers. Previously payments from the hospitals for these visits were difficult to obtain and it often took multiple reminders and chasing from the College’s administrator to settle the outstanding balances. Through better communication and implementation of late fees, this financial period saw an improved pattern of timely payments from hospitals visited, although some payments were not made until 2025.
There were 8-unit accreditation visits undertaken between December 2023 and November 2024, they are listed below:
-
Southampton General Hospital – visit date 28/12/2023 – payment 22/02/2024
-
Bart’s Nuffield Hospital – visit date 07/02/2024 – payment 08/01/2025
-
University Hospital Wales, Cardiff – visit date 19/03/2024 – payment 24/09/2024
-
Beacon Hospital, Dublin – Training status visit, date 07/06/2024 – expenses paid 25/10/2024
-
Glenfield Hospital, Sheffield – visit date 11/06/2024 – payment 14/03/2025
-
BMI Alexandra Hospital, Manchester – visit date 24/09/2024 – payment not yet received
-
Edinburgh Royal Infirmary – visit date 18/10/2024 – payment 21/02/2025
-
Wythenshawe Hospital, Manchester visit date 24/10/2024 – payment 15/01/2025
As can be seen from the payment dates, some of the fees were paid after the financial period end of 20232024.
The perfusion community is kept informed of all the College's income and expenditure regularly at the Annual General meeting each year and the College Council meet 4/5 times per year where a Treasurer update is provided each meeting. These meetings both in-person and virtually, took place as followed:
-
16/01/2024 – CCPS meeting, Royal College of Surgeons, London
-
11/03/2024 - CCPS meeting, Royal College of Surgeons, London
-
28/06/2024 - CCPS meeting, Royal College of Surgeons, London
-
11/09/2024 - CCPS meeting, Royal College of Surgeons, London
-
14/11/2024 – CCPS meeting at SCPS AGM, Glasgow ICC
- 5 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Trustees' annual report (incorporating the directors' report) (continued)
Year ended 30 November 2024
Financial review
The college had total income for the year of £66,470 (2023 £68,518), and expenditure of £49,546 (2023: £54,971) resulting in net income of £16,924 (2023: net income of £13,547).
The Collage has been able to maintain financial stability during the 2023-2024 period with a healthy balance in comparison to the last few years. The College is able to hold the agreed upon Reserve level.
The primary source of income for the College is the annual re-registration fee from each registrant. The registration fee for 2024 was £90. Some additional charges from late fees incurred after failure for members to pay within the designated timeframe are included. Income from registration for this period was £44,681. This is identical to the previous financial period. It was discussed at the College Council meetings that because the registration fee is the biggest generator of income for the College, that it was time the fee amount was reviewed. The registration fees have not seen an increase since 2019, when it was raised from £75 to £90, and with the current increase in cost of living and to bring in line with the increase in fees from similar professional bodies it was decided that the annual fee should be increased to £120 per registrant and this would be brought into effect in the next financial period. It was announced to the membership during the College's AGM in Glasgow in November 2024.
The second source of income is generally derived from perfusion department accreditation visits. This was £27,212 for visits undertaken in this period. All visits came under the £3,000 fee, but the Beacon visit was only charged the expenses incurred as it was not a full accreditation visit but a meeting to determine application for training status. As can be seen above there are still some issues in getting the hospitals to pay the fee in a timely manner. Of the 8 visits, half of them were paid in the next financial period.
During the 2023-24 period there was no additional income generated through course validation fees or other means.
The business account that was established between the College and Society with Premier Inn hotels has continued to work well. This has allowed for discounted rates for rooms for assessors when travelling to attend Unit Accreditation visits and helps to streamline the costs of expenses for these visits. Where possible assessors are encouraged to make use of this service and can be booked directly with the College's administrator. This has seen a decrease in the cost of hotel stays on these visits for this financial period. However, one disadvantage is that not all bookings are able to be pre-paid. This is due to location of the hotels or timeframe when booked in relation to the visits. Despite this, the assessors still get the discounted rate but reclaim the cost through submitted expenses to the College. This has meant that the incurred expenses of some of the visits can still be quite high.
The College has continued to seek out legal advice and proper guidance in safety matters, documentation review and support for fitness to practice/breach of conduct investigations. The subsequent cost of the additional support has been deemed necessary to protect both the College and membership from potential future legal costs and we expect to see more cost incurred as a result.
Reserves policy
As of 30th November 2024, the charity had unrestricted free reserves (represented by unrestricted current assets less unrestricted current liabilities of £87,230 (2023: £70,306).
The Trustees approved a policy of holding reserves of £45,000 in 2022 and the same reserve was agreed for 2023 and 2024. This has been held comfortably in this financial period. This can be review in next period with the increased income from additional registration fee income. Reserves are defined as the amount of unrestricted funds available to the trustees for use in the objects of the charity.
- 6 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Trustees' annual report (incorporating the directors' report) (continued)
Year ended 30 November 2024
Plans for future periods
At present there is still no statutory regulation of the Clinical Perfusion Scientist profession by the government. The society remains focused on the possibility of statutory regulation, under the terms that will best serve not only our membership but also our patient group. The College has agreed with the Society Executive that the funds contributed to Society Education fund can also be used in the pursuit of statutory regulation. The College will continue to hold the register for the profession until statutory regulation is attained.
The Society of Clinical Perfusion Scientists asked the College in 2022 to make a contribution towards the education fund that is in place for the membership. This falls under point the College's constitution point 3.6 To fund scholarships and exhibitions and to make grants, and to give prizes, and to give and participate in any arrangements made with any university or institute of higher education or any other body having the appropriate powers whereby students or former students of the College may become qualified to receive any degrees or other academic qualifications provided that no certificate, diploma or other award shall contain any statement expressing or 5 implying that it is granted by or under the authority of the Department of Trade or any Government Department except to such extent as may be authorised by the Department of Trade or the department concerned.
The contribution was made to the Society who are responsible for the Education and Training of the membership. The fund has been used towards the cost of education content such as the Spring seminar, the cost of establishing a medicine management course and any other education related courses or seminars that would take place that have been or will be organised by the Society. A contribution of £10,000 was made in the financial period 2021-2022. No further contribution has been made as the Society has indicated that the initial fund is not yet depleted, and they will not seek further contribution until this is the case, but the College is prepared to make another contribution when requested and supports the Society in the quest for statutory regulation.
Structure, governance and management
The organisation is a charitable company limited by guarantee, incorporated on 29 January 1986 and registered as a charity on 18 February 1986. The company was established under a Memorandum of Association that established the objects and powers of the charitable company and is governed under its Articles of Association.
The importance of training and strengthening the College's governance management became a focus during this financial period. In May 2024 some of the trustees attended training in GDPR through an online seminar. There were also multiple discussions and steps taken in updating and creating better pathways for the College Council members to access and make better use of documentation and streamlining College processes. An action log has been implemented to keep better track of tasks assigned to council members. This process has also included the investment of employing expert advise to ensure due process is being followed. This is aimed at protecting the Council if there are any legal proceedings in the future. The possibility of employing auditors to assess the College processes and documentation will be explored in the next period and consideration given to the trustees also undergoing Audit training.
- 7 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Trustees' annual report (incorporating the directors' report) (continued)
Year ended 30 November 2024
Structure, governance and management (continued)
Trustees
The trustees who served during the year and up to the date of this report as listed on page 1.
The trustees are the Council of Management of The College of Clinical Perfusion Scientists of Great Britain and Ireland and are made up as follows:
-
Up to 8 nominated by the Society of Clinical Perfusionist Scientists of Great Britain and Ireland.
-
The Registrar of the Society of Clinical Perfusion Scientists of Great Britain and Ireland.
-
Two surgeons nominated by the Society of Cardiothoracic Surgery (SCTS).
-
Two anaesthetists nominated by the Association of Cardiothoracic Anaesthetists (ACTA).
-
An Academic Clinician co-opted by the council as advisor for education.
Small company provisions
This report has been prepared taking advantage of the small companies' exemption of section 415A of the Companies Act 2006.
The trustees' annual report was approved on .............................. and signed on behalf of the board of trustees by:
A Brennan (Treasurer) Trustee
- 8 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Independent examiner's report to the trustees of The College of Clinical Perfusion Scientists of Great Britain and Ireland
Year ended 30 November 2024
I report to the charity trustees on my examination of the financial statements of the company for the year ended 30 November 2024 which comprise the statement of financial activities (including income and expenditure account), balance sheet and the related notes.
Responsibilities and basis of report
As the charity trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 Act’).
Having satisfied myself that the financial statements of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your company's financial statements as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or
-
the financial statements do not accord with those records; or
-
the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair' view which is not a matter considered as part of an independent examination; or
-
the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Mark Proctor FCA DChA Independent Examiner
Lovewell Blake LLP Chartered accountants Bankside 300 Peachman Way Broadland Business Park Norwich NR7 0LB
- 9 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Statement of financial activities (including income and expenditure account)
Year ended 30 November 2024
| 2024 | 2024 | 2023 | ||
|---|---|---|---|---|
| Unrestricted | ||||
| funds | Total funds | Total funds | ||
| Note | £ | £ | £ | |
| Income and endowments | ||||
| Charitable activities | 5 | 66,393 | 66,393 | 67,680 |
| Investment income | 6 | 77 | 77 | 48 |
| Other income | 7 | – | – | 790 |
|
|
|
||
| Total income | 66,470 | 66,470 | 68,518 | |
|
|
|
||
| Expenditure | ||||
| Charitable activities | 8 | (49,546) | (49,546) | (54,971) |
|
|
|
||
| Total expenditure | (49,546) | (49,546) | (54,971) | |
|
|
|
||
|
|
|
||
| Net income and net movement in funds | 16,924 | 16,924 | 13,547 | |
|
|
|
||
| Reconciliation of funds | ||||
| Total funds brought forward | 70,306 | 70,306 | 56,759 | |
|
|
|
||
| Total funds carried forward | 87,230 | 87,230 | 70,306 | |
|
|
|
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
The notes on pages 12 to 16 form part of these financial statements.
- 10 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Balance sheet
30 November 2024
| 2024 | 2023 | ||||
|---|---|---|---|---|---|
| Note | £ | £ | £ | £ | |
| Current assets | |||||
| Debtors | 12 | 17,297 | 8,500 | ||
| Cash at bank and in hand | 83,133 | 84,218 | |||
|
|
||||
| 100,430 | 92,718 | ||||
| Creditors: Amounts falling due within | |||||
| one year | 13 | (13,200) | (22,412) | ||
|
|
||||
| Net current assets | 87,230 | 70,306 | |||
|
|
||||
| Total assets less current liabilities | 87,230 | 70,306 | |||
|
|
||||
| Funds of the charity | |||||
| Unrestricted funds | 87,230 | 70,306 | |||
|
|
||||
| Total charity funds | 14 | 87,230 |
70,306 |
For the year ending 30 November 2024 the charity was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
These financial statements were approved by the board of trustees and authorised for issue on ........................, and are signed on behalf of the board by:
A Brennan (Treasurer) Trustee
Company registration number: 01983718
The notes on pages 12 to 16 form part of these financial statements.
- 11 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Notes to the financial statements
Year ended 30 November 2024
1. General information
The charity is a public benefit entity and a private company limited by guarantee, registered in England and Wales and a registered charity in England and Wales. The address of the registered office is Royal College of Surgeons of England, College of Clinical Perfusion Scientists, Fifth Floor, Lincoln's Inn Fields, London, WC2A 3PE.
2. Statement of compliance
The charity constitutes a public benefit entity as defined by FRS 102. The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102), the Charities Act 2011, the Companies Act 2006 and UK Generally Accepted Accounting Practice.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The financial statements have been prepared on a going concern basis as the trustees believe that no material uncertainties exist. The trustees have considered the level of funds held and the expected level of income and expenditure for 12 months from authorising these financial statements. The budgeted income and expenditure is sufficient with the level of reserves for the charity to be able to continue as a going concern.
Income
All income is included in the statement of financial activities when entitlement has passed to the charity, it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income:
-
registration, accreditation and exam fees are recognised on an accrual basis in the Statement of Financial Activities in the year they are receivable, which is when the charity becomes entitled to resource.
-
investment income is accounted for on a receivable basis gross of any income tax recoverable.
-
income from contracts for the supply of services is recognised with the delivery of the contracted service. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent, in which case it may be regarded as restricted.
- 12 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Notes to the financial statements (continued)
Year ended 30 November 2024
3. Accounting policies (continued)
Expenditure
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:
- expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities.
All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Current assets and current liabilities are subsequently measured at the cash or other consideration expected to be paid or received and not discounted.
Debt instruments are subsequently measured at amortised cost.
4. Limited by guarantee
The College has no share capital and the liability of the members is limited by guarantee to £1 each.
5. Charitable activities
| Unrestricted | Total Funds | Unrestricted | Total Funds | |
|---|---|---|---|---|
| Funds | 2024 | Funds | 2023 | |
| £ | £ | £ | £ | |
| Registration fees | 44,681 | 44,681 | 44,800 | 44,800 |
| Accreditation visits | 21,712 | 21,712 | 22,530 | 22,530 |
| Exam fees | – | – | 350 | 350 |
|
|
|
|
|
| 66,393 | 66,393 | 67,680 | 67,680 | |
|
|
|
|
|
| Investment income | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | |
| Funds | 2024 | Funds | 2023 | |
| £ | £ | £ | £ | |
| Bank interest receivable | 77 | 77 | 48 | 48 |
|
|
|
|
6. Investment income
- 13 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Notes to the financial statements (continued)
Year ended 30 November 2024
| 7. | Other income | ||||
|---|---|---|---|---|---|
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2024 | Funds | 2023 | ||
| £ | £ | £ | £ | ||
| Other income | – | – | 790 | 790 | |
|
|
|
|
||
| 8. | Expenditure on charitable activities | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2024 | Funds | 2023 | ||
| £ | £ | £ | £ | ||
| Travelling | 6,701 | 6,701 | 9,884 | 9,884 | |
| General administration costs | 31,443 | 31,443 | 33,536 | 33,536 | |
| Insurance | 2,480 | 2,480 | 1,014 | 1,014 | |
| AGM expenses | 7,153 | 7,153 | 7,255 | 7,255 | |
| Sundry expenses | (1,245) | (1,245) | 66 | 66 | |
| World pay/fast pay | 524 | 524 | 249 | 249 | |
| Conference registration fees | – | – | 407 | 407 | |
| Governance costs | 2,490 | 2,490 | 2,560 | 2,560 | |
|
|
|
|
||
| 49,546 | 49,546 | 54,971 | 54,971 | ||
|
|
|
|
||
| Analysis of governance costs | |||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2024 | Funds | 2023 | ||
| £ | £ | £ | £ | ||
| Independent examination | 2,490 | 2,490 | 2,560 | 2,560 | |
|
|
|
|
||
| 9. | Net income | ||||
| Net income is stated after charging/(crediting): | |||||
| 2024 | 2023 | ||||
| £ | £ | ||||
| Independent examiners fee | 2,490 | 2,560 | |||
|
|
10. Staff costs
There were no staff costs incurred during the year.
The average head count of employees during the year was Nil (2023: Nil)
No employee received employee benefits of more than £60,000 during the year (2023: Nil)
11. Trustee remuneration and expenses
None of the trustees (or any persons connected with them) received any remuneration during the year. Eight trustees were due or reimbursed in the year expenses of £5,007 (2023: Eleven trustees, £6,625).
At the year-end £271 was owed to one of the trustees (2023: £nil owed to trustees).
- 14 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Notes to the financial statements (continued)
Year ended 30 November 2024
| 12. | Debtors | ||||
|---|---|---|---|---|---|
| 2024 | 2023 | ||||
| £ | £ | ||||
| Trade debtors | 15,600 | 8,500 | |||
| Prepayments and accrued income | 1,697 | – | |||
|
|
||||
| 17,297 | 8,500 | ||||
|
|
||||
| 13. | Creditors: Amounts falling due within | one year | |||
| 2024 | 2023 | ||||
| £ | £ | ||||
| Accruals | 13,200 | 22,412 | |||
|
|
||||
| 14. | Analysis of charitable funds | ||||
| Unrestricted funds | |||||
| 2024 | |||||
| At 1 | At 30 | ||||
| December | November | ||||
| 2023 | Income | Expenditure | 2024 | ||
| £ | £ | £ | £ | ||
| General funds | 70,306 | 66,470 | (49,546) | 87,230 | |
|
|
|
|
||
| 2023 | |||||
| At 1 | At 30 | ||||
| December | November | ||||
| 2022 | Income | Expenditure | 2023 | ||
| £ | £ | £ | £ | ||
| General funds | 56,759 | 68,518 | (54,971) | 70,306 | |
|
|
|
|
- 15 -
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Company Limited by Guarantee
Notes to the financial statements (continued)
Year ended 30 November 2024
15. Analysis of net assets between funds
| Unrestricted | Total Funds | |
|---|---|---|
| Funds | 2024 | |
| £ | £ | |
| Current assets | 100,430 | 100,430 |
| Creditors less than 1 year | (13,200) | (13,200) |
|
|
|
| Net assets | 87,230 | 87,230 |
|
|
|
| Unrestricted | Total Funds | |
| Funds | 2023 | |
| £ | £ | |
| Current assets | 92,718 | 92,718 |
| Creditors less than 1 year | (22,412) | (22,412) |
|
|
|
| Net assets | 70,306 | 70,306 |
|
|
16. Related parties
There were no related party transactions in the current or previous year other than those detailed in note 11.
- 16 -